Van Andel Institute
Tracked across 2 events · 12 articles · First seen Apr 15, 2026 · Last active Sep 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Van Andel Institute is a key institution in this event, as its scientists, including Hong Li, co-led the research and analyzed ThermoCas9's structure, demonstrating its ability to selectively target tumor DNA.
Apr 15, 2026 · 6 articles
Tech
The phase 2 EVITA trial, a randomized, double-blind, placebo-controlled study, tested whether high-dose oral vitamin C (1000 mg/day for 12 months) could benefit patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies, conditions…
Impact: Co-led the EVITA trial through its VAI-SU2C Epigenetics Dream Team and provided co-senior author Peter A. Jones; the positive exploratory signal enhances its research reputation.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Van Andel Institute live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard